ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Venom Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-30W8817
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Venom Market Outlook 2022
BUY CHAPTERS

Global Anti-Venom Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-30W8817
Report
June 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Haffkine Bio Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL Limited
Pfizer Inc
Merck
BTG Plc

Anti-Venom Market Size

In 2024, the global market size of Anti-Venom was estimated to be worth US$ 1041 million and is forecast to reach approximately US$ 1383 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Anti-Venom Market

Anti-Venom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Venom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Venom.
The Anti-Venom market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Venom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Venom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Anti-Venom Market Report

Report Metric Details
Report Name Anti-Venom Market
CAGR 4.2%
Segment by Type
  • Polyvalent Anti-Venom
  • Monovalent Anti-Venom
Segment by Application
  • Non-profit Institutions
  • Hospitals and Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Anti-Venom in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Anti-Venom manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Venom sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the CSL, Merck, BTG, Pfizer, Haffkine Bio Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm share in Anti-Venom Market?

Ans: CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm.

What is the Anti-Venom Market share by region?

Ans: Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume.

Who are the main players in the Anti-Venom Market report?

Ans: The main players in the Anti-Venom Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm

What are the Application segmentation covered in the Anti-Venom Market report?

Ans: The Applications covered in the Anti-Venom Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the Anti-Venom Market report?

Ans: The Types covered in the Anti-Venom Market report are Polyvalent Anti-Venom, Monovalent Anti-Venom

Recommended Reports

Antibody Drugs

Anti-Infective Markets

Therapeutics & Adjuvants

1 Study Coverage
1.1 Anti-Venom Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Venom Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Polyvalent Anti-Venom
1.2.3 Monovalent Anti-Venom
1.3 Market by Application
1.3.1 Global Anti-Venom Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Venom Market Size Estimates and Forecasts
2.1.1 Global Anti-Venom Revenue 2020-2031
2.1.2 Global Anti-Venom Sales 2020-2031
2.2 Anti-Venom Market Size by Region: 2024 Versus 2031
2.3 Anti-Venom Sales by Region (2020-2031)
2.3.1 Global Anti-Venom Sales by Region: 2020-2025
2.3.2 Global Anti-Venom Sales Forecast by Region (2026-2031)
2.3.3 Global Anti-Venom Sales Market Share by Region (2020-2031)
2.4 Anti-Venom Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Anti-Venom Revenue by Region: 2020-2025
2.4.2 Global Anti-Venom Revenue Forecast by Region (2026-2031)
2.4.3 Global Anti-Venom Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anti-Venom Sales by Type (2020-2031)
3.1.1.1 Global Anti-Venom Sales Volume by Type (2020-2031)
3.1.1.2 Global Anti-Venom Sales Market Share by Type (2020-2031)
3.1.2 Global Anti-Venom Revenue by Type (2020-2031)
3.1.2.1 Global Anti-Venom Revenue by Type (2020-2031)
3.1.2.2 Global Anti-Venom Revenue Market Share by Type (2020-2031)
3.1.3 Anti-Venom Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anti-Venom Sales by Application (2020-2031)
3.2.1.1 Global Anti-Venom Sales Volume by Application (2020-2031)
3.2.1.2 Global Anti-Venom Sales Market Share by Application (2020-2031)
3.2.2 Global Anti-Venom Revenue by Application (2020-2031)
3.2.2.1 Global Anti-Venom Revenue by Application (2020-2031)
3.2.2.2 Global Anti-Venom Revenue Market Share by Application (2020-2031)
3.2.3 Anti-Venom Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Polyvalent Anti-Venom of Anti-Venom Revenue Market Share by Application
3.3.2 Monovalent Anti-Venom of Anti-Venom Revenue Market Share by Application
4 Global Anti-Venom by Manufacturers
4.1 Global Top Anti-Venom Manufacturers by Sales (2020-2025)
4.1.1 Global Anti-Venom Sales by Manufacturer (2020-2025)
4.1.2 Global Anti-Venom Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Anti-Venom Manufacturers by Revenue (2020-2025)
4.2.1 Global Anti-Venom Revenue by Manufacturer (2020-2025)
4.2.2 Global Anti-Venom Revenue Share by Manufacturer (2020-2025)
4.3 Global Anti-Venom Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Anti-Venom Manufacturers Covered: Ranking by Revenue
4.4.2 Global Anti-Venom Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Anti-Venom Manufacturing Base Distribution, Product Type
4.5.1 Anti-Venom Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Anti-Venom Market
4.5.3 Manufacturers Anti-Venom Product Type and Application
4.5.4 Polyvalent Anti-Venom Market Sales of Anti-Venom by Manufacturer
4.5.5 Monovalent Anti-Venom Market Sales of Anti-Venom by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL
5.1.1 CSL Company Information
5.1.2 CSL Description, Business Overview
5.1.3 CSL Anti-Venom Products Offered
5.1.4 CSL Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Anti-Venom Sales by Product in 2024
5.1.6 CSL Anti-Venom Sales by Application in 2024
5.1.7 CSL Anti-Venom Sales by Geographic Area in 2024
5.1.8 CSL Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Anti-Venom Products Offered
5.2.4 Merck Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Anti-Venom Sales by Product in 2024
5.2.6 Merck Anti-Venom Sales by Application in 2024
5.2.7 Merck Anti-Venom Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 BTG
5.3.1 BTG Company Information
5.3.2 BTG Description, Business Overview
5.3.3 BTG Anti-Venom Products Offered
5.3.4 BTG Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.3.5 BTG Anti-Venom Sales by Product in 2024
5.3.6 BTG Anti-Venom Sales by Application in 2024
5.3.7 BTG Anti-Venom Sales by Geographic Area in 2024
5.3.8 BTG Recent Developments
5.4 Pfizer
5.4.1 Pfizer Company Information
5.4.2 Pfizer Description, Business Overview
5.4.3 Pfizer Anti-Venom Products Offered
5.4.4 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Pfizer Anti-Venom Sales by Product in 2024
5.4.6 Pfizer Anti-Venom Sales by Application in 2024
5.4.7 Pfizer Anti-Venom Sales by Geographic Area in 2024
5.4.8 Pfizer Recent Developments
5.5 Haffkine Bio-Pharmaceutical
5.5.1 Haffkine Bio-Pharmaceutical Company Information
5.5.2 Haffkine Bio-Pharmaceutical Description, Business Overview
5.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
5.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Haffkine Bio-Pharmaceutical Anti-Venom Sales by Product in 2024
5.5.6 Haffkine Bio-Pharmaceutical Anti-Venom Sales by Application in 2024
5.5.7 Haffkine Bio-Pharmaceutical Anti-Venom Sales by Geographic Area in 2024
5.5.8 Haffkine Bio-Pharmaceutical Recent Developments
5.6 Rare Disease Therapeutics
5.6.1 Rare Disease Therapeutics Company Information
5.6.2 Rare Disease Therapeutics Description, Business Overview
5.6.3 Rare Disease Therapeutics Anti-Venom Products Offered
5.6.4 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Rare Disease Therapeutics Anti-Venom Sales by Product in 2024
5.6.6 Rare Disease Therapeutics Anti-Venom Sales by Application in 2024
5.6.7 Rare Disease Therapeutics Anti-Venom Sales by Geographic Area in 2024
5.6.8 Rare Disease Therapeutics Recent Developments
5.7 Flynn Pharma
5.7.1 Flynn Pharma Company Information
5.7.2 Flynn Pharma Description, Business Overview
5.7.3 Flynn Pharma Anti-Venom Products Offered
5.7.4 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Flynn Pharma Anti-Venom Sales by Product in 2024
5.7.6 Flynn Pharma Anti-Venom Sales by Application in 2024
5.7.7 Flynn Pharma Anti-Venom Sales by Geographic Area in 2024
5.7.8 Flynn Pharma Recent Developments
5.8 Vins Bioproducts
5.8.1 Vins Bioproducts Company Information
5.8.2 Vins Bioproducts Description, Business Overview
5.8.3 Vins Bioproducts Anti-Venom Products Offered
5.8.4 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Vins Bioproducts Anti-Venom Sales by Product in 2024
5.8.6 Vins Bioproducts Anti-Venom Sales by Application in 2024
5.8.7 Vins Bioproducts Anti-Venom Sales by Geographic Area in 2024
5.8.8 Vins Bioproducts Recent Developments
5.9 Bharat Serums and Vaccines
5.9.1 Bharat Serums and Vaccines Company Information
5.9.2 Bharat Serums and Vaccines Description, Business Overview
5.9.3 Bharat Serums and Vaccines Anti-Venom Products Offered
5.9.4 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Bharat Serums and Vaccines Anti-Venom Sales by Product in 2024
5.9.6 Bharat Serums and Vaccines Anti-Venom Sales by Application in 2024
5.9.7 Bharat Serums and Vaccines Anti-Venom Sales by Geographic Area in 2024
5.9.8 Bharat Serums and Vaccines Recent Developments
5.10 Serum Biotech
5.10.1 Serum Biotech Company Information
5.10.2 Serum Biotech Description, Business Overview
5.10.3 Serum Biotech Anti-Venom Products Offered
5.10.4 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Serum Biotech Anti-Venom Sales by Product in 2024
5.10.6 Serum Biotech Anti-Venom Sales by Application in 2024
5.10.7 Serum Biotech Anti-Venom Sales by Geographic Area in 2024
5.10.8 Serum Biotech Recent Developments
5.11 MicroPharm
5.11.1 MicroPharm Company Information
5.11.2 MicroPharm Description, Business Overview
5.11.3 MicroPharm Anti-Venom Products Offered
5.11.4 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2020-2025)
5.11.5 MicroPharm Anti-Venom Sales by Product in 2024
5.11.6 MicroPharm Anti-Venom Sales by Application in 2024
5.11.7 MicroPharm Anti-Venom Sales by Geographic Area in 2024
5.11.8 MicroPharm Recent Developments
6 North America
6.1 North America Anti-Venom Market Size YoY Growth 2020-2031
6.2 North America Anti-Venom Market Facts & Figures by Country
6.2.1 North America Anti-Venom Sales by Country (2020-2031)
6.2.2 North America Anti-Venom Revenue by Country (2020-2031)
6.3 North America Anti-Venom Sales by Type (2020-2025)
6.4 North America Anti-Venom Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anti-Venom Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anti-Venom Market Facts & Figures by Region
7.2.1 Asia-Pacific Anti-Venom Sales by Region (2020-2031)
7.2.2 Asia-Pacific Anti-Venom Revenue by Region (2020-2031)
7.3 Asia-Pacific Anti-Venom Sales by Type (2020-2025)
7.4 Asia-Pacific Anti-Venom Sales by Application (2020-2025)
8 Europe
8.1 Europe Anti-Venom Market Size YoY Growth 2020-2031
8.2 Europe Anti-Venom Market Facts & Figures by Country
8.2.1 Europe Anti-Venom Sales by Country (2020-2031)
8.2.2 Europe Anti-Venom Revenue by Country (2020-2031)
8.3 Europe Anti-Venom Sales by Type (2020-2025)
8.4 Europe Anti-Venom Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Anti-Venom Market Size YoY Growth 2020-2031
9.2 Latin America Anti-Venom Market Facts & Figures by Country
9.2.1 Latin America Anti-Venom Sales by Country (2020-2031)
9.2.2 Latin America Anti-Venom Revenue by Country (2020-2031)
9.3 Latin America Anti-Venom Sales by Type (2020-2025)
9.4 Latin America Anti-Venom Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anti-Venom Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anti-Venom Market Facts & Figures by Country
10.2.1 Middle East and Africa Anti-Venom Sales by Country (2020-2031)
10.2.2 Middle East and Africa Anti-Venom Revenue by Country (2020-2031)
10.3 Middle East and Africa Anti-Venom Sales by Type (2020-2025)
10.4 Middle East and Africa Anti-Venom Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anti-Venom Supply Chain Analysis
11.2 Anti-Venom Key Raw Materials and Upstream Suppliers
11.3 Anti-Venom Clients Analysis
11.4 Anti-Venom Sales Channel and Sales Model Analysis
11.4.1 Anti-Venom Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anti-Venom Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anti-Venom Distributors
12 Anti-Venom Market Dynamics
12.1 Anti-Venom Industry Trends
12.2 Anti-Venom Market Drivers
12.3 Anti-Venom Market Challenges
12.4 Anti-Venom Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Haffkine Bio Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL Limited
Pfizer Inc
Merck
BTG Plc
List of Tables
 Table 1. Global Anti-Venom Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Anti-Venom Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Anti-Venom Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Anti-Venom Sales by Region (2020-2025) & (K Vials)
 Table 5. Global Anti-Venom Sales Forecast by Region (2026-2031) & (K Vials)
 Table 6. Global Anti-Venom Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Anti-Venom Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Anti-Venom Sales Volume by Type (2020-2025) & (K Vials)
 Table 9. Global Anti-Venom Sales Volume by Type (2026-2031) & (K Vials)
 Table 10. Global Anti-Venom Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Anti-Venom Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Anti-Venom Sales Volume by Application (2020-2025) & (K Vials)
 Table 13. Global Anti-Venom Sales Volume by Application (2026-2031) & (K Vials)
 Table 14. Global Anti-Venom Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Anti-Venom Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Anti-Venom Sales by Manufacturer (2020-2025) & (K Vials)
 Table 17. Global Anti-Venom Sales Share by Manufacturer (2020-2025)
 Table 18. Anti-Venom Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Anti-Venom Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Anti-Venom Price (2020-2025) & (USD/Vial)
 Table 21. Ranking of Global Top Anti-Venom Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Anti-Venom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2024)
 Table 24. Anti-Venom Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Anti-Venom Market
 Table 26. Manufacturers Anti-Venom Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. CSL Company Information
 Table 29. CSL Description and Business Overview
 Table 30. CSL Anti-Venom Product
 Table 31. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 32. CSL Sales Proportion of Anti-Venom by Product in 2024
 Table 33. CSL Sales Proportion of Anti-Venom by Application in 2024
 Table 34. CSL Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 35. CSL Recent Developments
 Table 36. Merck Company Information
 Table 37. Merck Description and Business Overview
 Table 38. Merck Anti-Venom Product
 Table 39. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 40. Merck Sales Proportion of Anti-Venom by Product in 2024
 Table 41. Merck Sales Proportion of Anti-Venom by Application in 2024
 Table 42. Merck Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 43. Merck Recent Developments
 Table 44. BTG Company Information
 Table 45. BTG Description and Business Overview
 Table 46. BTG Anti-Venom Product
 Table 47. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 48. BTG Sales Proportion of Anti-Venom by Product in 2024
 Table 49. BTG Sales Proportion of Anti-Venom by Application in 2024
 Table 50. BTG Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 51. BTG Recent Developments
 Table 52. Pfizer Company Information
 Table 53. Pfizer Description and Business Overview
 Table 54. Pfizer Anti-Venom Product
 Table 55. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 56. Pfizer Sales Proportion of Anti-Venom by Product in 2024
 Table 57. Pfizer Sales Proportion of Anti-Venom by Application in 2024
 Table 58. Pfizer Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 59. Pfizer Recent Developments
 Table 60. Haffkine Bio-Pharmaceutical Company Information
 Table 61. Haffkine Bio-Pharmaceutical Description and Business Overview
 Table 62. Haffkine Bio-Pharmaceutical Anti-Venom Product
 Table 63. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 64. Haffkine Bio-Pharmaceutical Sales Proportion of Anti-Venom by Product in 2024
 Table 65. Haffkine Bio-Pharmaceutical Sales Proportion of Anti-Venom by Application in 2024
 Table 66. Haffkine Bio-Pharmaceutical Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 67. Haffkine Bio-Pharmaceutical Recent Developments
 Table 68. Rare Disease Therapeutics Company Information
 Table 69. Rare Disease Therapeutics Description and Business Overview
 Table 70. Rare Disease Therapeutics Anti-Venom Product
 Table 71. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 72. Rare Disease Therapeutics Sales Proportion of Anti-Venom by Product in 2024
 Table 73. Rare Disease Therapeutics Sales Proportion of Anti-Venom by Application in 2024
 Table 74. Rare Disease Therapeutics Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 75. Rare Disease Therapeutics Recent Developments
 Table 76. Flynn Pharma Company Information
 Table 77. Flynn Pharma Description and Business Overview
 Table 78. Flynn Pharma Anti-Venom Product
 Table 79. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 80. Flynn Pharma Sales Proportion of Anti-Venom by Product in 2024
 Table 81. Flynn Pharma Sales Proportion of Anti-Venom by Application in 2024
 Table 82. Flynn Pharma Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 83. Flynn Pharma Recent Developments
 Table 84. Vins Bioproducts Company Information
 Table 85. Vins Bioproducts Description and Business Overview
 Table 86. Vins Bioproducts Anti-Venom Product
 Table 87. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 88. Vins Bioproducts Sales Proportion of Anti-Venom by Product in 2024
 Table 89. Vins Bioproducts Sales Proportion of Anti-Venom by Application in 2024
 Table 90. Vins Bioproducts Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 91. Vins Bioproducts Recent Developments
 Table 92. Bharat Serums and Vaccines Company Information
 Table 93. Bharat Serums and Vaccines Description and Business Overview
 Table 94. Bharat Serums and Vaccines Anti-Venom Product
 Table 95. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 96. Bharat Serums and Vaccines Sales Proportion of Anti-Venom by Product in 2024
 Table 97. Bharat Serums and Vaccines Sales Proportion of Anti-Venom by Application in 2024
 Table 98. Bharat Serums and Vaccines Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 99. Bharat Serums and Vaccines Recent Developments
 Table 100. Serum Biotech Company Information
 Table 101. Serum Biotech Description and Business Overview
 Table 102. Serum Biotech Anti-Venom Product
 Table 103. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 104. Serum Biotech Sales Proportion of Anti-Venom by Product in 2024
 Table 105. Serum Biotech Sales Proportion of Anti-Venom by Application in 2024
 Table 106. Serum Biotech Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 107. Serum Biotech Recent Developments
 Table 108. MicroPharm Company Information
 Table 109. MicroPharm Description and Business Overview
 Table 110. MicroPharm Anti-Venom Product
 Table 111. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 112. MicroPharm Sales Proportion of Anti-Venom by Product in 2024
 Table 113. MicroPharm Sales Proportion of Anti-Venom by Application in 2024
 Table 114. MicroPharm Sales Proportion of Anti-Venom by Geographic Area in 2024
 Table 115. MicroPharm Recent Developments
 Table 116. North America Anti-Venom Sales by Country (2020-2025) & (K Vials)
 Table 117. North America Anti-Venom Sales by Country (2026-2031) & (K Vials)
 Table 118. North America Anti-Venom Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Anti-Venom Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Anti-Venom Sales by Type (2020-2025) & (K Vials)
 Table 121. North America Anti-Venom Sales by Application (2020-2025) & (K Vials)
 Table 122. Asia-Pacific Anti-Venom Sales by Region (2020-2025) & (K Vials)
 Table 123. Asia-Pacific Anti-Venom Sales by Region (2026-2031) & (K Vials)
 Table 124. Asia-Pacific Anti-Venom Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Anti-Venom Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Anti-Venom Sales by Type (2020-2025) & (K Vials)
 Table 127. Asia-Pacific Anti-Venom Sales by Application (2020-2025) & (K Vials)
 Table 128. Europe Anti-Venom Sales by Country (2020-2025) & (K Vials)
 Table 129. Europe Anti-Venom Sales by Country (2026-2031) & (K Vials)
 Table 130. Europe Anti-Venom Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Anti-Venom Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Anti-Venom Sales by Type (2020-2025) & (K Vials)
 Table 133. Europe Anti-Venom Sales by Application (2020-2025) & (K Vials)
 Table 134. Latin America Anti-Venom Sales by Country (2020-2025) & (K Vials)
 Table 135. Latin America Anti-Venom Sales by Country (2026-2031) & (K Vials)
 Table 136. Latin America Anti-Venom Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Anti-Venom Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Anti-Venom Sales by Type (2020-2025) & (K Vials)
 Table 139. Latin America Anti-Venom Sales by Application (2020-2025) & (K Vials)
 Table 140. Middle East and Africa Anti-Venom Sales by Country (2020-2025) & (K Vials)
 Table 141. Middle East and Africa Anti-Venom Sales by Country (2026-2031) & (K Vials)
 Table 142. Middle East and Africa Anti-Venom Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Anti-Venom Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Anti-Venom Sales by Type (2020-2025) & (K Vials)
 Table 145. Middle East and Africa Anti-Venom Sales by Application (2020-2025) & (K Vials)
 Table 146. Anti-Venom Key Raw Materials, Industry Status and Trend
 Table 147. Anti-Venom Key Raw Materials and Upstream Suppliers
 Table 148. Anti-Venom Clients Status and Trend
 Table 149. Anti-Venom Typical Clients
 Table 150. Anti-Venom Distributors
 Table 151. Anti-Venom Market Trends
 Table 152. Anti-Venom Market Drivers
 Table 153. Anti-Venom Market Challenges
 Table 154. Anti-Venom Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Anti-Venom Product Picture
 Figure 2. Global Anti-Venom Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Anti-Venom Sales Market Share by Type in 2024 & 2031
 Figure 4. Polyvalent Anti-Venom Product Picture
 Figure 5. Monovalent Anti-Venom Product Picture
 Figure 6. Global Anti-Venom Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Anti-Venom Sales Market Share by Application in 2024 & 2031
 Figure 8. Non-profit Institutions
 Figure 9. Hospitals and Clinic
 Figure 10. Anti-Venom Report Years Considered
 Figure 11. Global Anti-Venom Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Anti-Venom Market Size 2020-2031 (US$ Million)
 Figure 13. Global Anti-Venom Sales 2020-2031 (K Vials)
 Figure 14. Global Anti-Venom Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Anti-Venom Revenue Market Share by Region (2020-2031)
 Figure 16. Global Anti-Venom Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Anti-Venom Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Anti-Venom Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
 Figure 19. Global Anti-Venom Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Anti-Venom Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Anti-Venom Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
 Figure 22. Polyvalent Anti-Venom of Anti-Venom Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Monovalent Anti-Venom of Anti-Venom Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Anti-Venom Sales Share by Manufacturer in 2024
 Figure 25. Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Polyvalent Anti-Venom Market Sales Proportion by Manufacturer in 2024
 Figure 27. Monovalent Anti-Venom Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Anti-Venom Revenue 2020-2031 (US$ Million)
 Figure 29. North America Anti-Venom Sales Market Share by Type (2020-2025)
 Figure 30. North America Anti-Venom Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Anti-Venom Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Anti-Venom Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Anti-Venom Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Anti-Venom Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Anti-Venom Sales Market Share by Application (2020-2025)
 Figure 36. Europe Anti-Venom Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Anti-Venom Sales Market Share by Country (2020-2031)
 Figure 38. Europe Anti-Venom Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Anti-Venom Sales Market Share by Type (2020-2025)
 Figure 40. Europe Anti-Venom Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Anti-Venom Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Anti-Venom Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Anti-Venom Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Anti-Venom Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Anti-Venom Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Anti-Venom Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Anti-Venom Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Anti-Venom Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Anti-Venom Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Anti-Venom Sales Market Share by Application (2020-2025)
 Figure 51. Anti-Venom Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Anti-Venom Raw Materials by Region in 2024
 Figure 53. Anti-Venom Distribution Channels
 Figure 54. Global Anti-Venom Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Anti-Venom Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Antivenom Market Insights Forecast to 2030
Global Antivenom Serum Market Research Report 2024
Monovalent Antivenom Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Polyvalent Antivenom Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antivenoms for Treating Spider Bites Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antivenin Market Insights Forecast to 2030
Global Venom Antiserum Market Insights Forecast to 2030
Global Snake Venom Antiserum Market Insights Forecast to 2030
Global Snake Antivenom Immunoglobulin Market Research Report 2024
Antivenene Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antivenom Immunoglobulin Market Research Report 2025
Global His Tag Antibody Market Research Report 2024
Global DCT Antibody Market Research Report 2024
Global Synaptotagmin 1 Antibody Market Research Report 2024
Global Research Grade Antibodies Market Research Report 2024
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Global Antiserum Market Research Report 2025
Global Antitoxin Serum Market Research Report 2024
NeuN Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venom Extractor Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions